Allergan plc (AGN) New York Stock Exchange
152.693.432.30%
CloseJanuary 15, 2019

News: updated – 16-Jan 01:34


Aurinia Offers A Lot Of Upside Potential With Upcoming Phase 2 Dry Eye Disease Study Readout15-Jan 06:36(SeekingAlpha)

Aurinia Pharmaceuticals ( AUPH ) is gearing up for an upcoming catalyst due any day now in January of 2019. It is expecting to report results from its phase 2 dry eye disease study soon. This dry eye disease study is important because it targets a large market. In addition, Voclosporin will …

FDA to beef up cell and gene therapy staff15-Jan 01:17(SeekingAlpha)

Citing the 800 active INDs for cell therapy and gene therapy candidates and the expectation that it will be receiving more that 200 INDs each year by 2020, FDA Commission Scott Gottlieb, M.D., outlines the agency’s initiatives to support timely review and to enable the approval of 10 – 20 …

FDA Commish touts advances/successes15-Jan 12:45(SeekingAlpha)

In a stream of tweets , FDA Commissioner Scott Gottlieb, M.D. details a number of accomplishments and advances by the agency. Highlights: More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wellness Rx Trust, Tekla World Healthcare Fund, Healthcare stocks …

CoolSculpting® and Sonja Morgan Partner To Get Real About Self-Care15-Jan 07:45(PR Newswire)

DUBLIN , Jan. 15, 2019 /PRNewswire/ –Television personality on Bravo’s "The Real Housewives of New York City ", philanthropist, fashion lifestyle entrepreneur and mom, Sonja Morgan , is partnering with CoolSculpting, owned by Allergan plc (NYSE: AGN), as the face of the brand’s l…